Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)

So far, Altmetric has seen 12 X posts from 6 X users, with an upper bound of 24,001 followers.

RT @sitcancer: #JITC Case Report: Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful tre…

RT @sitcancer: #JITC Case Report: Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful tre…

#JITC Case Report: Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy https://t.co/Xegi2VihH9 https://t.co/RawaWfyfEo

RT @sitcancer: #JITC Case Report: Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful tre…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.